Canada markets closed

Acorda Therapeutics, Inc. (CDG.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
8.420.00 (0.00%)
At close: 03:32PM CEST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
115,664
117,633
118,566
129,071
152,967
-
Cost of Revenue
15,756
15,283
30,332
40,787
33,513
-
Gross Profit
99,908
102,350
88,234
88,284
119,454
-
Operating Expenses
Research Development
4,720
5,152
5,804
10,420
23,012
-
Selling General and Administrative
95,555
89,698
106,256
124,399
152,576
-
Total Operating Expenses
123,992
125,614
130,270
165,583
206,351
-
Operating Income or Loss
-24,084
-23,264
-42,036
-77,299
-86,897
-
Interest Expense
32,337
31,533
30,200
30,035
30,574
-
Total Other Income/Expenses Net
-248,602
-241,754
35,080
-1,745
8,988
-
Income Before Tax
-304,440
-296,021
-35,247
-109,074
-107,667
-
Income Tax Expense
-41,015
-43,167
30,669
-5,120
-8,073
-
Income from Continuing Operations
-263,425
-252,854
-65,916
-103,954
-99,594
-
Net Income
-263,425
-252,854
-65,916
-103,954
-99,594
-
Net Income available to common shareholders
-263,425
-252,854
-65,916
-103,954
-99,594
-
Basic EPS
2.61
-
-66.80
-195.80
-246.40
-688.60
Diluted EPS
2.61
-
-66.80
-195.80
-246.40
-688.60
Basic Average Shares
1,264
-
985.35
531.05
404.2
396.349
Diluted Average Shares
1,264
-
985.35
531.05
404.2
396.349